Research suggests that mindfulness-based stress reduction shows promis

A study led by Georgetown University Medical Center found that a guided Mindfulness-Based Stress Reduction (MBSR) program is as effective as the antidepressant escitalopram in treating anxiety disorders. The randomized clinical trial involved 276 patients who either participated in an eight-week MBSR program or took escitalopram. Both groups experienced a significant reduction in anxiety symptoms, with a mean decrease of approximately 30%. The findings suggest that MBSR is a viable non-pharmacological treatment option for anxiety disorders.

MBSR is as effective as escitalopram

The study demonstrated that an eight-week MBSR program led to a comparable reduction in anxiety symptoms as the antidepressant escitalopram.

Non-pharmacological alternative

MBSR offers a treatment option for individuals who prefer to avoid medication or experience adverse effects from antidepressants.

Structured program

The MBSR program included weekly two-and-a-half-hour classes, a day-long retreat, and daily 45-minute home practice exercises.

High completion rates

Approximately 90% of participants completed the MBSR program, indicating good adherence and acceptability.

Potential for broader implementation

Given its effectiveness and structured format, MBSR could be integrated into various healthcare settings as a standard treatment for anxiety disorders.